- Home
- BCBP vs PBYI Comparison
BCBP vs PBYI Comparison
Compare BCBP & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- PBYI
- Stock Information
- Founded
- BCBP 2000
- PBYI 2010
- Country
- BCBP United States
- PBYI United States
- Employees
- BCBP N/A
- PBYI N/A
- Industry
- BCBP Savings Institutions
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- PBYI Health Care
- Exchange
- BCBP Nasdaq
- PBYI Nasdaq
- Market Cap
- BCBP 143.5M
- PBYI 171.7M
- IPO Year
- BCBP N/A
- PBYI N/A
- Fundamental
- Price
- BCBP $8.66
- PBYI $4.42
- Analyst Decision
- BCBP Hold
- PBYI Strong Buy
- Analyst Count
- BCBP 2
- PBYI 1
- Target Price
- BCBP $9.50
- PBYI $7.00
- AVG Volume (30 Days)
- BCBP 51.7K
- PBYI 543.3K
- Earning Date
- BCBP 10-17-2025
- PBYI 11-06-2025
- Dividend Yield
- BCBP 7.41%
- PBYI N/A
- EPS Growth
- BCBP N/A
- PBYI 434.29
- EPS
- BCBP 0.19
- PBYI 0.97
- Revenue
- BCBP $65,498,000.00
- PBYI $238,062,000.00
- Revenue This Year
- BCBP $22.81
- PBYI N/A
- Revenue Next Year
- BCBP $8.60
- PBYI N/A
- P/E Ratio
- BCBP $45.22
- PBYI $4.51
- Revenue Growth
- BCBP N/A
- PBYI 8.63
- 52 Week Low
- BCBP $7.54
- PBYI $2.32
- 52 Week High
- BCBP $14.04
- PBYI $6.07
- Technical
- Relative Strength Index (RSI)
- BCBP 48.39
- PBYI 45.14
- Support Level
- BCBP $8.52
- PBYI $4.30
- Resistance Level
- BCBP $8.89
- PBYI $4.72
- Average True Range (ATR)
- BCBP 0.17
- PBYI 0.25
- MACD
- BCBP -0.03
- PBYI -0.11
- Stochastic Oscillator
- BCBP 28.72
- PBYI 10.53
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.